Clinical Trial Update: Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial investigating GWP42003-P as adjunctive therapy in schizophrenia with inadequate response to antipsychotics; study terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• GWP42003-P

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Schizophrenia | Phase 2 | Status: TERMINATED | Results posted: 2023-06-15